US2005158797A1PendingUtilityA1
Mammalian CDP-diacylglycerol synthase
Est. expiryMar 31, 2019(expired)· nominal 20-yr term from priority
Inventors:David Leung
C12N 9/1241C12Y 207/07041
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is disclosed cDNA sequences and polypeptides having the enzyme CDP-diacylglycerol synthase (CDS) activity. CDS is also known as CTP:phosphatidate cytidylyltransferase. There is further disclosed methods for isolation and production of polypeptides involved in phosphatidic acid metabolism and signaling in mammalian cells, in particular, the production of purified forms of CDS.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method for determining whether a compound is a useful pharmaceutical compound, comprising (a) contacting a first sample of a polypeptide that comprises an amino acid sequence of FIG. 8 (SEQ ID NO: 12) that has CDP-diacylglycerol synthase (CDS) activity with (i) at least one substrate for the polypeptide and (ii) at least one compound; (b) contacting a second sample of the polypeptide with the substrate but not with the compound; and (c) determining whether the CDS activity of the polypeptide of the first sample is increased or decreased in comparison to the CDS activity of the polypeptide of the second sample, wherein an increase or decrease in the CDS activity of the polypeptide of the first sample indicates that the compound modulates CDS activity and is a useful pharmaceutical compound.Join the waitlist — get patent alerts
Track US2005158797A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.